HTG Molecular Diagnostics (HTGM) Reports Q4 Loss of $0.76/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to HTG Molecular Diagnostics (HTGM) Reports Q4 Loss of $0.76/Share

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results

March 23, 2017 4:03 PM EDT

TUCSON, Ariz., March 23, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM), a provider of instruments, reagents and services for molecular profiling applications, today reported financial results for the fourth quarter and year ended December 31, 2016.

Recent Accomplishments & Highlights:

Signed a development, manufacturing and commercialization agreement with a wholly owned affiliate of QIAGEN, N.V.  QIAGEN North American Holdings also made a minority investment in HTGs common stock  Completed technical feasibility assay for QIAGEN GeneReader next-generation sequencing platformObtained CE marking for the HTG EdgeSeq... More